Bioconjugate pneumococcal vaccine (LimmaTech)

N/A

Report date: 2023/09/12 20:11:36

Base Information

Drug NameBioconjugate pneumococcal vaccine (LimmaTech)

Drug Alias NamePneumo1

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia, BacterialPneumonia, Pneumococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesLimmatech Biologics Ag

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLimmatech Biologics Ag

Active IndicationsN/A

Inactive IndicationsPneumonia, BacterialPneumonia, Pneumococcal

Other Information

ATC CodeN/A